Association of APOE Serum Levels and
APOE
optic neuritis (ON)
ε3/ε3
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
01 07 2022
01 07 2022
Historique:
received:
09
06
2022
revised:
22
06
2022
accepted:
27
06
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
29
7
2022
Statut:
epublish
Résumé
Optical neuritis (ON), otherwise known as optical nerve damage, is a term used to describe various environmental and body conditions that lead to optic nerve dysfunction. Neurologists are well aware of conditions that cause optic neuropathy, such as trauma, infections, malnutrition, and various toxins. As optic neuritis is a multifactorial demyelinating or infectious process, genetic predisposition may also influence the progression of optic neuritis. This study aimed to evaluate the association of ON (with and without multiple sclerosis) with
Identifiants
pubmed: 35885971
pii: genes13071188
doi: 10.3390/genes13071188
pmc: PMC9323366
pii:
doi:
Substances chimiques
ApoE protein, human
0
Apolipoprotein E2
0
Apolipoprotein E3
0
Apolipoproteins E
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Mult Scler. 2009 Mar;15(3):311-5
pubmed: 19244396
Neurosci Lett. 2000 Dec 22;296(2-3):174-6
pubmed: 11109009
J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):532
pubmed: 10847793
Ann Clin Biochem. 1998 Jan;35 ( Pt 1):135-6
pubmed: 9463752
J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):203-5
pubmed: 10406990
Am J Ophthalmol. 1998 Mar;125(3):353-9
pubmed: 9512153
Nucleic Acids Res. 2005 Oct 04;33(17):e149
pubmed: 16204452
J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):290-5
pubmed: 16484634
Mol Cell Probes. 1994 Dec;8(6):519-25
pubmed: 7700274
J Biol Chem. 2000 Oct 27;275(43):33679-87
pubmed: 10930413
Mult Scler. 2003 Aug;9(4):382-6
pubmed: 12926843
Neurology. 1999 Sep 11;53(4):888-9
pubmed: 10489065
J Neurol. 2003 Sep;250(9):1094-8
pubmed: 14504972
J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):25-8
pubmed: 10864599
BMC Res Notes. 2019 Sep 24;12(1):630
pubmed: 31551090
Acta Neurol Scand. 2000 Aug;102(2):94-8
pubmed: 10949525
Mult Scler. 2002 Apr;8(2):98-103
pubmed: 11990879
Neurology. 2001 Sep 11;57(5):853-7
pubmed: 11552016
Arch Neurol. 1999 Dec;56(12):1484-7
pubmed: 10593303
Pract Neurol. 2016 Apr;16(2):96-110
pubmed: 26764409
Mult Scler. 2004 Apr;10(2):153-7
pubmed: 15124760
J Ophthalmol. 2018 Mar 15;2018:1686297
pubmed: 29736281
Eye (Lond). 2011 Jul;25(7):833-42
pubmed: 21527960
Folia Neuropathol. 2019;57(2):87-105
pubmed: 31556570
Mult Scler. 2004 Jun;10(3):272-7
pubmed: 15222690
Am Fam Physician. 2013 May 15;87(10):712-4
pubmed: 23939450
Eye Brain. 2016 Oct 26;8:195-202
pubmed: 28539814
Arch Neurol. 2003 Jan;60(1):65-70
pubmed: 12533090
Mol Neurodegener. 2016 Jan 12;11:2
pubmed: 26754117
Mult Scler. 2000 Aug;6(4):226-30
pubmed: 10962542
Aging (Albany NY). 2019 Jan 24;11(2):787-816
pubmed: 30677746
Mult Scler. 2000 Feb;6(1):32-6
pubmed: 10694843
Am J Hum Genet. 1998 Jul;63(1):200-6
pubmed: 9634502
J Clin Neurosci. 2019 Aug;66:83-86
pubmed: 31126849
Am J Hum Genet. 2002 Mar;70(3):708-17
pubmed: 11836653
J Neuropathol Exp Neurol. 2000 May;59(5):361-7
pubmed: 10888365
Alzheimers Dement (Amst). 2020 Feb 06;12(1):e12008
pubmed: 32211503
Mult Scler. 2004 Jun;10(3):266-71
pubmed: 15222689
Neurology. 2004 Mar 9;62(5):811-4
pubmed: 15007140
Continuum (Minneap Minn). 2019 Oct;25(5):1236-1264
pubmed: 31584536
Neurology. 2001 Feb 13;56(3):312-6
pubmed: 11171894
Eur Rev Med Pharmacol Sci. 2011 Oct;15(10):1122-30
pubmed: 22165672
Mult Scler. 2005 Oct;11(5):511-5
pubmed: 16193886
Clin Chim Acta. 1999 Aug;286(1-2):115-43
pubmed: 10511288
Clin Dev Immunol. 2010;2010:186813
pubmed: 20613949
Acta Neurol Scand. 1999 Nov;100(5):290-5
pubmed: 10536914
Gene. 2019 Jul 20;706:154-161
pubmed: 31054363